UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bisphosphonates, Old Friends of Bones and New Trends in Clinics

Journal of medicinal chemistry, 2021-02, Vol.64 (3), p.1260-1282

2021

Volltextzugriff (PDF)

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

The New England journal of medicine, 2012-11, Vol.367 (18), p.1714-1723

2012

Volltextzugriff (PDF)

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

The journal of clinical endocrinology and metabolism, 2011-04, Vol.96 (4), p.972-980

2011

Volltextzugriff (PDF)

Long-Term Use of Bisphosphonates in Osteoporosis

The journal of clinical endocrinology and metabolism, 2010-04, Vol.95 (4), p.1555-1565

2010

Volltextzugriff (PDF)

Discovery of Novel Antiosteoporosis Leads with Bone Resorption Inhibition and Anabolic Promotion through a Chemotype-Assembly Approach

Journal of medicinal chemistry, 2024-09, Vol.67 (17), p.15311-15327

2024

Volltextzugriff (PDF)

The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs

Injury, 2018-08, Vol.49 (8), p.1461-1465

Hak, David J.

2018

Volltextzugriff (PDF)

A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial

Journal of bone and mineral research, 2012-08, Vol.27 (8), p.1821-1829

2012

Volltextzugriff (PDF)

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study

Journal of clinical pharmacology, 2014-02, Vol.54 (2), p.168-178

2014

Volltextzugriff (PDF)

Mechanism of Action, Pharmacokinetic and Pharmacodynamic Profile, and Clinical Applications of Nitrogen-containing Bisphosphonates

Journal of Dental Research, 2007-11, Vol.86 (11), p.1022-1033

Kimmel, D.B.

2007

Volltextzugriff (PDF)

Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate

International journal of pharmaceutics, 2020-05, Vol.582, p.119312, Article 119312

2020

Volltextzugriff (PDF)

Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur

Osteoporosis international, 2018-02, Vol.29 (2), p.501-506

2018

Volltextzugriff (PDF)

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

The New England journal of medicine, 2017-10, Vol.377 (15), p.1417-1427

2017

Volltextzugriff (PDF)

Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial

Osteoporosis international, 2013-01, Vol.24 (1), p.227-235

2013

Volltextzugriff (PDF)

Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages

Current pharmaceutical design, 2010-09, Vol.16 (27), p.2950-2960

2010

Volltextzugriff (PDF)

A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

Journal of bone and mineral research, 2011-09, Vol.26 (9), p.2261-2270

2011

Volltextzugriff (PDF)

Management of Osteoporosis in Chronic Kidney Disease

Internal Medicine, 2017/12/15, Vol.56(24), pp.3271-3276

2017

Volltextzugriff (PDF)

Biovalorization of soybean residue (okara) via fermentation with Ganoderma lucidum and Lentinus edodes to attain products with high anti-osteoporotic effects

Journal of bioscience and bioengineering, 2020-04, Vol.129 (4), p.514-518

2020

Volltextzugriff (PDF)

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

The New England journal of medicine, 2014-01, Vol.370 (5), p.412-420

2014

Volltextzugriff (PDF)

Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice

American journal of physiology: endocrinology and metabolism, 2014-06, Vol.306 (12), p.E1418-E1430

2014

Volltextzugriff (PDF)

Fenugreek steroidal saponins hinder osteoclastogenic bone resorption by targeting CSF-1R which diminishes the RANKL/OPG ratio

International journal of biological macromolecules, 2021-09, Vol.186, p.351-364

2021

Volltextzugriff (PDF)

Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women

The journal of clinical endocrinology and metabolism, 2010-01, Vol.95 (1), p.151-158

2010

Volltextzugriff (PDF)

Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)

Biological and Pharmaceutical Bulletin, 2017/06/01, Vol.40(6), pp.739-750

2017

Volltextzugriff (PDF)

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

The Lancet (British edition), 2015-09, Vol.386 (9999), p.1147-1155

2015

Volltextzugriff (PDF)

Vitamin D compounds for people with chronic kidney disease not requiring dialysis

Cochrane database of systematic reviews, 2009-10 (4), p.CD008175

2009

Volltextzugriff (PDF)

A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis

Osteoporosis international, 2019-10, Vol.30 (10), p.2027-2037

2019

Volltextzugriff (PDF)

1 – 25 von 15.178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13.557)
Mit Volltextzugriff
(11.672)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(13.398)
Science & Technology
(12.389)
Life Sciences & Biomedicine
(12.129)
Female
(8.923)
Bone Density Conservation Agents - Therapeutic Use
(8.728)
Male
(5.328)
Osteoporosis
(5.031)
Aged
(4.974)
Middle Aged
(4.662)
Bone Density Conservation Agents - Adverse Effects
(3.893)
Osteoporosis - Drug Therapy
(3.695)
Bone Density Conservation Agents - Administration & Dosage
(3.689)
Diphosphonates - Therapeutic Use
(3.626)
Endocrinology & Metabolism
(3.132)
Animals
(2.769)
Orthopedics
(2.762)
Bone Density Conservation Agents - Pharmacology
(2.670)
Bone Density - Drug Effects
(2.648)
Bisphosphonates
(2.616)
Medicine
(2.552)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(15.078)
Ingenta.com
(7.510)
Journals@Ovid
(6.766)
EZB Electronic Journals Library
(4.932)
Springer Nature - Complete Springer Journals
(3.538)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(2.890)
NUS Single-Journal Subscriptions
(2.830)
Elsevier ScienceDirect Journals Complete
(2.668)
IngentaConnect Journals
(2.031)
Wiley Online Library All Journals
(1.741)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.705)
Wiley Online Library Full Collection 2018
(1.372)
Oxford journals
(902)
Taylor & Francis Journals Auto-Holdings Collection
(658)
Taylor & Francis
(596)
Taylor & Francis Journals Complete
(558)
Oxford Journals 2020 Medicine
(528)
Nature
(276)
SAGE Complete
(263)
BMJ Journals
(244)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Bisphosphonates, Old Friends of Bones and New Trends in Clinics

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

Long-Term Use of Bisphosphonates in Osteoporosis

Discovery of Novel Antiosteoporosis Leads with Bone Resorption Inhibition and Anabolic Promotion through a Chemotype-Assembly Approach

The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs

A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study

Mechanism of Action, Pharmacokinetic and Pharmacodynamic Profile, and Clinical Applications of Nitrogen-containing Bisphosphonates

Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate

Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial

Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages

A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

Management of Osteoporosis in Chronic Kidney Disease

Biovalorization of soybean residue (okara) via fermentation with Ganoderma lucidum and Lentinus edodes to attain products with high anti-osteoporotic effects

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice

Fenugreek steroidal saponins hinder osteoclastogenic bone resorption by targeting CSF-1R which diminishes the RANKL/OPG ratio

Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women

Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

Vitamin D compounds for people with chronic kidney disease not requiring dialysis

A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis

Suchergebnisse filtern